C. Ronald Blankenship's Insider Trades & SAST Disclosures
C. Ronald Blankenship's most recent trade in Civeo Corp was a trade of 6,021 Common Shares done . Disclosure was reported to the exchange on May 14, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern C. Ronald Blankenship.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Civeo Corp | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 6,021 | 50,822 (0%) | 0% | 0 | Common Shares | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2025 | 1,875 | 1,875 | - | - | Restricted Stock Grant | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2025 | 2,284 | 91 | - | - | Restricted Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2025 | 2,284 | 110,346 (0%) | 0% | - | Common Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2025 | 481 | 110,918 (0%) | 0% | - | Common Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2025 | 91 | 0 | - | - | Dividend Equivalent Rights | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2025 | 91 | 110,437 (0%) | 0% | - | Common Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 478 | 108,541 (0%) | 0% | - | Common Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2024 | 506 | 108,063 (0%) | 0% | - | Common Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2024 | 584 | 107,557 (0%) | 0% | - | Common Stock | |
| Civeo Corp | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 5,051 | 44,801 (0%) | 0% | 0 | Common Shares | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 2,284 | 2,284 | - | - | Restricted Stock Grant | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 2,263 | 106,336 (0%) | 0% | - | Common Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 2,263 | 72 | - | - | Restricted Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 565 | 106,973 (0%) | 0% | - | Common Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 72 | 106,408 (0%) | 0% | - | Common Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 72 | 0 | - | - | Dividend Equivalent Rights | |
| Regency Centers Corporation | Blankenship Ronald C. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 566 | 94,774 (0%) | 0% | - | Common Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 588 | 93,654 (0%) | 0% | - | Common Stock | |
| Civeo Corp | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 5,947 | 39,750 (0%) | 0% | 0 | Common Shares | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 2,263 | 4,310 | - | - | Restricted Stock Grant | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2023 | 1,962 | 92,425 (0%) | 0% | - | Common Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2023 | 1,962 | 2,348 | - | - | Restricted Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 556 | 93,066 (0%) | 0% | - | Common Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2023 | 85 | 92,510 (0%) | 0% | - | Common Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2023 | 85 | 2,263 | - | - | Dividend Equivalent Rights | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 570 | 90,463 (0%) | 0% | - | Common Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2022 | 572 | 89,893 (0%) | 0% | - | Common Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 528 | 89,321 (0%) | 0% | - | Common Stock | |
| Civeo Corp | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 4,879 | 33,803 (0%) | 0% | 0 | Common Shares | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2022 | 2,158 | 88,716 (0%) | 0% | - | Common Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2022 | 2,158 | 1,962 | - | - | Restricted Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2022 | 77 | 0 | - | - | Dividend Equivalent Rights | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2022 | 77 | 88,793 (0%) | 0% | - | Common Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 1,831 | 3,831 | - | - | Restricted Stock Grant | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 500 | 86,558 (0%) | 0% | - | Common Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 485 | 86,058 (0%) | 0% | - | Common Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 528 | 85,573 (0%) | 0% | - | Common Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2021 | 553 | 85,045 (0%) | 0% | - | Common Stock | |
| Civeo Corp | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 7,627 | 28,924 (0%) | 0% | 0 | Common Shares | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2021 | 2,662 | 2,000 | - | - | Restricted Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2021 | 2,662 | 84,293 (0%) | 0% | - | Common Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2021 | 2,000 | 4,662 | - | - | Restricted Stock Grant | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2021 | 672 | 81,631 (0%) | 0% | - | Common Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2021 | 199 | 0 | - | - | Dividend Equivalent Rights | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2021 | 199 | 84,492 (0%) | 0% | - | Common Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2021 | 814 | 72,215 (0%) | 0% | - | Common Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2020 | 852 | 71,401 (0%) | 0% | - | Common Stock | |
| Regency Centers Corporation | C. Ronald Blankenship | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2020 | 867 | 70,549 (0%) | 0% | - | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges